The objective response rate for LM was 51.6%, including a 15.6% complete response, and the disease control rate was 81.3% by BICR in the LM efficacy evaluable ... supporting its effective CNS ...

Abstract: Single-phase ac/dc or dc/ac systems are inherently subject to ... In view of this, this paper presents a symmetrical half-bridge circuit which utilizes the dc-link capacitors to absorb the ...

Don't miss out on the headlines from Celebrity Life. Followed categories will be added to My News. Indeed, the 30-year-old Australian looked a dead ringer for Kardashian in the photo where she ...

Mumbai’s underground Metro Line-3 took a big step forward with the opening of its Phase 2A on May 9, connecting Bandra-Kurla Complex (BKC) to Acharya Atre Chowk in Worli. The new stretch was ...

Seranthony Domínguez retired the side in order in the bottom of the 11th for his first save. Bryan Baker (3-0) allowed one run in the 10th and picked up the win. O'Hearn went 4 for 6 and drove in two ...

rNIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK sUniversity Hospitals Sussex NHS Foundation Trust, ...

Merck, known as MSD outside of the United States and Canada, announced that the phase 3 KEYNOTE-B96 trial, also known as ENGOT-ov65, met its primary endpoint of progression-free survival (PFS) for the ...

Phase II Study (NO LIMIT, WJOG13320G ... One hundred seventy patients (142 events) were needed to detect an increase of 3 months in PFS with 80% power (log-rank test, 5% two-sided α). One hundred ...

But with promising early results from a phase 3 study in certain patients, the checkpoint inhibitor may have found its place. At a pre-specified interim analysis of Merck’s phase 3 Keynote-B96 ...

Next shoppers have said they "can't wait to go away" on their summer holidays after snapping up the "perfect" dress for the occasion. The Halterneck Maxi Dress With Linen is a popular choice at ...

A low dose combination hormonal patch was found to be effective for pregnancy prevention based on results from a phase 3 study. The investigational transdermal delivery system, known as Xulane Lo ™, ...